ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,909Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 623

$665K Total Retail Price of All Prescriptions

Rank: 19 out of 623

486 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 486 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

13% of this provider’s 486 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

2% of this provider’s 11,236 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $66 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
LEVOTHYROXINE SODIUM 503 420 1 4
FUROSEMIDE 489 424 2 5
LISINOPRIL 450 377 3 1
AMLODIPINE BESYLATE 439 414 4 3
OMEPRAZOLE 347 246 5 7
SIMVASTATIN 342 314 6 2
METOPROLOL TARTRATE 275 258 7 9
METFORMIN HCL 258 207 8 6
TRAMADOL HCL 254 222 9 15
PRAVASTATIN SODIUM 249 169 10 11
METOPROLOL SUCCINATE 224 210 11 13
WARFARIN SODIUM 219 207 12 14
PANTOPRAZOLE SODIUM 196 154 13 26
SERTRALINE HCL 190 155 14 20
HYDROCHLOROTHIAZIDE 185 155 15 8
ATORVASTATIN CALCIUM 183 168 16 10
VENLAFAXINE HCL ER 177 160 17 96
HYDROCODONE-ACETAMINOPHEN 177 172 S3 17 17
CITALOPRAM HBR 176 147 19 21
FENTANYL 157 149 S2 20 76
ZOLPIDEM TARTRATE 156 119 21 22
GLIMEPIRIDE 151 137 22 38
JANTOVEN 150 150 23 54
BUSPIRONE HCL 147 133 24 94
PREDNISONE 136 113 25 40
LEVOFLOXACIN 128 106 26 72
CLOPIDOGREL 120 100 27 34
DIGOXIN 110 110 28 63
KLOR-CON M20 110 95 28 62
ESCITALOPRAM OXALATE 107 87 30 60
DONEPEZIL HCL 106 94 31 27
GABAPENTIN 105 98 32 18
ATENOLOL 103 88 33 12
DIOVAN 98 81 34 48
RANITIDINE HCL 96 57 35 23
MIRTAZAPINE 96 88 35 31
ALLOPURINOL 95 71 37 44
QUETIAPINE FUMARATE 87 53 38 51
PAROXETINE HCL 87 26 38 66
LANTUS 84 75 40 41
TRAZODONE HCL 83 66 41 36
PLAVIX 81 67 42 46
TAMSULOSIN HCL 78 74 43 35
LAMOTRIGINE 76 26 44 201
POTASSIUM CHLORIDE 76 74 44 24
LOSARTAN POTASSIUM 76 64 44 16
ALBUTEROL SULFATE 76 75 44 69
METOCLOPRAMIDE HCL 76 50 44 165
GLIPIZIDE 72 44 49 33
CLONIDINE HCL 69 42 50 55
SULFAMETHOXAZOLE-TRIMETHOPRIM 66 62 51 78
BACLOFEN 65 29 52 115
CRESTOR 62 47 53 28
GEMFIBROZIL 61 46 54 110
ALENDRONATE SODIUM 60 54 55 37
NITROFURANTOIN 59 34 56 209
SINGULAIR 58 29 57 109
NEXIUM 58 29 57 43
NOVOLOG 57 47 59 75
BENAZEPRIL HCL 56 56 60 106
OXYCODONE-ACETAMINOPHEN 53 51 S2 61 42
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.